|
 | Up a level |
Cheemanapalli, S and Palaniappan, C and Mahesh, Y and Iyyappan, Y and Yarrappagaari, S and Kanagaraj, S (2022) In vitro and in silico perspectives to explain anticancer activity of a novel syringic acid analog ((4-(1H-1, 3-benzodiazol-2-yl)-2, 6-dimethoxy phenol)) through apoptosis activation and NFkB inhibition in K562 leukemia cells. In: Computers in Biology and Medicine, 152 .
